|Bid||12.30 x 100|
|Ask||13.55 x 1000|
|Day's range||13.21 - 13.80|
|52-week range||4.41 - 14.05|
|PE ratio (TTM)||-8.88|
|Earnings date||7 Aug 2017 - 11 Aug 2017|
|Dividend & yield||N/A (N/A)|
|1y target est||14.75|
Momentum stocks continue to run on strong technicals and favorable news. Here are four to keep an eye on.
CRANBURY, N.J., July 18, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced the closing of its previously announced offering ...
After an about-face at the FDA sent shares soaring earlier this week, management announced a stock offering to bolster its balance sheet.